These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9711235

  • 21. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł, Fendler W, Młynarski W.
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [Abstract] [Full Text] [Related]

  • 22. Altered islet prohormone processing: a cause or consequence of diabetes?
    Ramzy A, Kieffer TJ.
    Physiol Rev; 2022 Jan 01; 102(1):155-208. PubMed ID: 34280055
    [Abstract] [Full Text] [Related]

  • 23. [Biological effects of proinsulin C-peptide].
    Kimura K.
    Seikagaku; 2005 May 01; 77(5):419-23. PubMed ID: 15952332
    [No Abstract] [Full Text] [Related]

  • 24. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
    Kirchhoff K, Machicao F, Haupt A, Schäfer SA, Tschritter O, Staiger H, Stefan N, Häring HU, Fritsche A.
    Diabetologia; 2008 Apr 01; 51(4):597-601. PubMed ID: 18264689
    [Abstract] [Full Text] [Related]

  • 25. [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)].
    Gerbitz KD.
    J Clin Chem Clin Biochem; 1980 Jun 01; 18(6):313-26. PubMed ID: 7000969
    [Abstract] [Full Text] [Related]

  • 26. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C.
    Diabetes Care; 1999 Apr 01; 22(4):609-14. PubMed ID: 10189540
    [Abstract] [Full Text] [Related]

  • 27. A brief perspective on insulin production.
    Steiner DF, Park SY, Støy J, Philipson LH, Bell GI.
    Diabetes Obes Metab; 2009 Nov 01; 11 Suppl 4():189-96. PubMed ID: 19817801
    [Abstract] [Full Text] [Related]

  • 28. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG.
    Diabetes; 1978 Nov 01; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract] [Full Text] [Related]

  • 29. Preparation of Tyr-C-peptide from genetically altered human insulin precursor.
    Sun H, Tang J, Hu M.
    Appl Biochem Biotechnol; 1995 Dec 01; 55(3):167-74. PubMed ID: 8579343
    [Abstract] [Full Text] [Related]

  • 30. Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells.
    Vollenweider F, Irminger JC, Halban PA.
    Diabetologia; 1993 Dec 01; 36(12):1322-5. PubMed ID: 8307263
    [Abstract] [Full Text] [Related]

  • 31. History and diagnostic significance of C-peptide.
    Brandenburg D.
    Exp Diabetes Res; 2008 Dec 01; 2008():576862. PubMed ID: 18509495
    [Abstract] [Full Text] [Related]

  • 32. [Proinsulin, des31-32 proinsulin].
    Inoue Y.
    Nihon Rinsho; 1998 Jan 01; 56 Suppl 3():27-34. PubMed ID: 9513384
    [No Abstract] [Full Text] [Related]

  • 33. Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?
    Nordquist L, Johansson M.
    Vasc Health Risk Manag; 2008 Jan 01; 4(6):1283-8. PubMed ID: 19337542
    [Abstract] [Full Text] [Related]

  • 34. On the role of the proinsulin C-peptide.
    Steiner DF.
    Diabetes; 1978 Jan 01; 27 Suppl 1():145-8. PubMed ID: 344111
    [Abstract] [Full Text] [Related]

  • 35. Proinsulin in development: New roles for an ancient prohormone.
    Hernández-Sánchez C, Mansilla A, de la Rosa EJ, de Pablo F.
    Diabetologia; 2006 Jun 01; 49(6):1142-50. PubMed ID: 16596360
    [Abstract] [Full Text] [Related]

  • 36. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.
    Furuta M, Carroll R, Martin S, Swift HH, Ravazzola M, Orci L, Steiner DF.
    J Biol Chem; 1998 Feb 06; 273(6):3431-7. PubMed ID: 9452465
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH.
    Clin Endocrinol (Oxf); 1996 Jun 06; 44(6):673-8. PubMed ID: 8759179
    [Abstract] [Full Text] [Related]

  • 38. Beta-cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing.
    Varlamov O, Fricker LD, Furukawa H, Steiner DF, Langley SH, Leiter EH.
    Endocrinology; 1997 Nov 06; 138(11):4883-92. PubMed ID: 9348219
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program.
    Majithia AR, Jablonski KA, McAteer JB, Mather KJ, Goldberg RB, Kahn SE, Florez JC, DPP Research Group.
    Diabetologia; 2011 Oct 06; 54(10):2570-4. PubMed ID: 21779873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.